A
Anne‐Claude Gingras
H指数:114
被引数:5.6万
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
The molecular glue CLEO4-88 inhibits the ACAA1 thiolase by induced binding to GID4
分子胶CLEO4-88通过诱导结合GID4抑制ACAA1硫解酶
Nature Chemical Biology
IF13.7
LncRNA CISTR-ACT regulates cell size in human and mouse by guiding FOSL2
长链非编码RNA CISTR-ACT通过引导FOSL2在人类和小鼠中调控细胞大小。
Nature Communications
IF15.7
Computational design and evaluation of optimal bait sets for scalable proximity proteomics
计算设计与评估适用于可扩展邻近蛋白质组学的最优诱饵集
Nature Communications
IF15.7
tRNA-overlapping long non-coding RNA loci repress codon-biased genes
tRNA重叠的长链非编码RNA位点抑制密码子偏好性基因
Cell Reports
IF6.9
Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medications
接受免疫抑制药物治疗的儿童接种COVID-19加强疫苗后的免疫原性
Pediatric Research
IF3.1
Cargo-selective regulation of clathrin-mediated endocytosis by AMP-activated protein kinase
AMP-激活蛋白激酶对网格蛋白介导的内吞作用的货物选择性调控
iScience
IF4.1
Optimizing Proximity Proteomics on the EvoSep-timsTOF LC–MS System
优化EvoSep-timsTOF LC–MS系统上的邻近蛋白质组学
PROTEOMICS
IF3.9
Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS-CoV-2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4+ T-Cell Activity
SARS-CoV-2 JN.1在既往感染过Omicron的移植受者中引起的纵向固有和异源适应性免疫反应:有限的中和作用但CD4+ T细胞活性强
Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023
SARS-CoV-2感染的加拿大医疗保健工作者队列风险因素:2020-2023
Validation of new equipment for SARS-CoV-2 diagnosis in Ecuador: Detection of the virus and antibodies generated by disease and vaccines with one POC device
厄瓜多尔SARS-CoV-2诊断新设备的验证:使用一种POC设备检测病毒及由疾病和疫苗产生的抗体
PLOS ONE
IF2.6
ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling
ShcD适配器蛋白通过异常激活EGFR信号通路驱动三阴性乳腺癌细胞的侵袭
MOLECULAR ONCOLOGY
IF4.5
Multimodal SARS-CoV-2 interactome sketches the virus-host spatial organization
多模态SARS-CoV-2相互作用组绘制了病毒-宿主的空间组织
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity
mRNA疫苗诱导的SARS-CoV-2刺突特异性ifn-γ 和IL-2 T细胞反应可预测血清学中和作用,并通过预先存在的交叉反应免疫而瞬时增强
JOURNAL OF VIROLOGY
IF3.8
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study
新型冠状病毒肺炎免疫介导的炎症性疾病的突破性感染: 来自Safety (新型冠状病毒肺炎疫苗在系统性自身免疫介导的炎症性疾病中的安全性和免疫原性) 研究的数据
VACCINES
IF3.4
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection
二价新型冠状病毒肺炎mRNA疫苗引起广泛的免疫反应和对Omicron亚变体感染的保护
NPJ VACCINES
IF6.5

